하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.
하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
HIRONIC, a global leader in non-invasive medical
aesthetic technology, has successfully hosted its inaugural 'HIRONIC Innovation
Summit 2025. Asia Edition' in Bangkok, Thailand on June 5th.
The event brought
together approximately 100 medical professionals and medical distribution
industry representatives from South Korea, Thailand, Vietnam, Malaysia,
Indonesia, Myanmar, and other countries. Across four in-depth clinical
sessions, speakers presented the latest approaches to skin rejuvenation,
covering multi-layered face and body lifting, advanced scar treatment, and
next-generation needle-free drug delivery technologies.
One of the keynote lectures was delivered by Dr. Wonkyu Hong,
Director and dermatologist at Human Dermatology Clinic and Executive Director
of the Human Clinical Trial Center in South Korea. Dr. Hong explored the
rapidly evolving role of needle-free technology in aesthetic medicine, sharing
his clinical experience while emphasizing both its therapeutic advantages and
its significant market growth potential driven by increasing patient demand for
non-invasive rejuvenation solutions.
Dr.Thitikom Limrattanamekha, founder
and CEO of Optima Aesthetics in Thailand and an experienced laser specialist in
scar treatment, skin quality improvement, and pigmentation management, shared
his expertise on combining pico laser
and RF microneedling to achieve highly effective outcomes in complex scarring
cases. His presentation highlighted how advanced combination protocols are
reshaping non-surgical treatment approaches and expanding therapeutic options
for physicians worldwide.
The symposium also provided a platform to showcase the clinical
advancements and growing market relevance of HIRONIC's flagship export
technologies, including New Doublo 2.0™, PICOHI™, and the latest needle-free delivery
system Synerjet PRO™. Sasha Borovtsova, Head of
Global Marketing Office at HIRONIC, stated, "This summit not only
showcased the real-world clinical applications of our technologies but also
underscored the accelerating global demand for safer, more versatile, and
highly effective aesthetic solutions. As innovation continues to drive market
growth, HIRONIC remains committed to advancing technology and strengthening
global expertise and partnerships through events like the HIRONIC Innovation
Summit."
